Thrombin activatable fibrinolysis inhibitor antigen could not be detected in cerebrospinal fluid

Jovan P. Antovic; Jan Hannerz; Michael Nekludov; Margareta Blombäck

doi:10.1055/s-0037-1616162

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 93(01): 178-179
DOI: 10.1055/s-0037-1616162

Letters to the Editor

Schattauer GmbH

Thrombin activatable fibrinolysis inhibitor antigen could not be detected in cerebrospinal fluid

Jovan P. Antovic

¹Karolinska University Hospital & Institute, Coagulation Research, Department of Surgical Sciences, Stockholm, Sweden

,

Jan Hannerz

²Karolinska University Hospital & Institute, Department of Neurology, Stockholm, Sweden

,

Michael Nekludov

³Department of Neurosurgery, Stockholm, Sweden

,

Margareta Blombäck

¹Karolinska University Hospital & Institute, Coagulation Research, Department of Surgical Sciences, Stockholm, Sweden

› Author Affiliations

References
1 Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin activable fibrinolysis inhibitor. J Biol Chem 1995; 270: 1477-84.
2 Wang W, Boffa MB, Bajzar L. et al A study of the mechanism of inhibition of fibrinolysis by activated thrombin activable fibrinolysis inhibitor. J Biol Chem 1998; 273: 27176-81.
3 Mosnier LO, von dem Borne PA, Meijers JC. et al Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb Haemost 1998; 80: 829-35.
4 Mosnier LO, Buijtenhuijs P, Marx PF. et al Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood 2003; 101: 4844-6.
5 Antovic JP. Thrombin activatable fibrinolysis inhibitor (TAFI) a link between coagulation and fibrinolysis. Clin Lab 2003; 49: 475-86.
6 Antovic JP, Yngen M, Östenson CG. et al Thrombin activatable fibrinolysis inhibitor (TAFI) and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications Blood Coag Fibrinolysis. 2003; 14: 551-6.
7 Bouma BN, Marx PF, Mosnier LO. et al Thrombin- activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U). Thromb Res 2001; 101: 329-54.
8 Wang W, Hendriks DF, Scharpe SS. Carboxy-peptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem 1994; 269: 15937-44.
9 Valnickova Z, Thogersen I B, Christensen S. et al Activated human plasma carboxypeptidase B is retained in the blood by binding to α 2 -macroglobulin and pregnancy zone protein. J Biol Chem 1996; 271: 12937-12943.
10 Fareed J, Callas DD, Hoppensteadt D. et al Tissue factor antigen levels in various biological fluids. Blood Coagul Fibrinolysis. 1995; 6 (Suppl. 01) S32-6.
11 Suzuki M, Kudo A, Otawara Y. et al Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage. Neurosurgery 1999; 44: 487-93.